ENTITY
Bayer

Bayer (BAYN GR)

70
Analysis
Health Care • Germany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
bullish•Monsanto Co
•28 May 2016 05:40

Monsanto/Bayer Deal to See Pushback from Farmers

The powerful farming lobby is already mobilizing opposition to the proposed merger of Bayer AG and Monsanto, which they see as further diminishing...

Logo
240 Views
Share
bullish•Monsanto Co
•23 May 2016 19:22

Monsanto/Bayer Deal Would Invite National Security and Vertical Overlap Reviews

An acquisition of US agricultural chemicals giant Monsanto by Germany’s Bayer AG would raise antitrust concerns in the US and abroad and would also...

Logo
279 Views
Share
bullish•Amgen Inc
•26 Mar 2016 10:49

Navigating Risk off Transition

ChartonicsEurope is the underperform short bet but our EM outperform hit a road block as copper turned down hard (sold down long exposure on March...

Share
bullish•Macroeconomics
•23 Mar 2016 17:13

Inflation - Really?

We're awash in concerns over inflation - the Economist last week, and multiple speakers at the 2nd Independent Research Conference where...

Logo
326 Views
Share
•12 Nov 2015 09:34

Healthcare Observer: As Long-Term Patent Exposure Ebbs, Innovation in Big Pharma Pipelines Support

Pipeline innovation outpacing patent losses represents a core element of the wide moat ratings for most of the Big Pharma firms. Slowing patent...

Share
x